Abstract:Background: Studies have shown inconsistent associations between serum uric acid (SUA) levels and mortality in peritoneal dialysis (PD) patients. We conducted this meta-analysis to determine whether SUA levels were associated with cardiovascular or all-cause mortality in PD patients. Methods: PubMed, Embase, Web of Science, the Cochrane Library, CNKI, VIP, Wanfang Database, and trial registry databases were systematically searched up to April 11, 2021. Cohort studies of SUA levels and cardiovascular or all-cause mortality in PD patients were obtained. Random effect models were used to calculate the pooled adjusted hazard ratio ( HR ) and corresponding 95% confidence interval ( CI ). Sensitivity analyses were conducted to assess the robustness of the pooled results. Subgroup analyses and meta-regression analyses were performed to explore the sources of heterogeneity. Funnel plots, Begg's tests, and Egger's tests were conducted to evaluate potential publication bias. The GRADE approach was used to rate the certainty of evidence. This study was registered with PROSPERO, CRD42021268739. Results: Seven studies covering 18,113 PD patients were included. Compared with the middle SUA levels, high SUA levels increased the risk of all-cause mortality ( HR = 1.74, 95% CI : 1.26–2.40, I 2 = 34.8%, τ 2 = 0.03), low SUA levels were not statistically significant with the risk of all-cause or cardiovascular mortality ( HR = 1.04, 95% CI : 0.84–1.29, I 2 = 43.8%, τ 2 = 0.03; HR = 0.89, 95% CI : 0.65–1.23, I 2 = 36.3%, τ 2 = 0.04; respectively). Compared with the low SUA levels, high SUA levels were not statistically associated with an increased risk of all-cause or cardiovascular mortality ( HR = 1.19, 95% CI : 0.59–2.40, I 2 = 88.2%, τ 2 = 0.44; HR = 1.22, 95% CI : 0.39–3.85, I 2 = 89.3%, τ 2 = 0.92; respectively). Conclusion: Compared with middle SUA levels, high SUA levels are associated with an increased risk of all-cause mortality in PD patients. SUA levels may not be associated with cardiovascular mortality. More high-level studies, especially randomized controlled trials, are needed to determine the association between SUA levels and cardiovascular or all-cause mortality in PD patients. Systematic Review Registration: https://www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42021268739 , identifier: CRD42021268739.

Uric Acid Levels and All-Cause Mortality in Peritoneal Dialysis Patients

High serum uric acid level is a mortality risk factor in peritoneal dialysis patients: a retrospective cohort study

The Associations of Uric Acid, Cardiovascular and All-Cause Mortality in Peritoneal Dialysis Patients.

The Significance of Follow-Up Serum Uric Acid Levels in Predicting All-Cause Mortality and Cardiovascular Mortality in Peritoneal Dialysis Patients.

Effects of Serum Uric Acid Level on All?cause Death and Cardiovascular Death in Patients of Maintaining Peritoneal Dialysis

An Inverse Relationship between Hyperuricemia and Mortality in Patients Undergoing Continuous Ambulatory Peritoneal Dialysis

Serum Uric Acid and Cardiovascular or All-Cause Mortality in Peritoneal Dialysis Patients: A Systematic Review and Meta-Analysis

Relationship between serum uric acid, all-cause mortality and cardiovascular mortality in peritoneal dialysis patients: systematic review and meta-analysis of cohort studies

Uric Acid to High-Density Lipoprotein Cholesterol Ratio Predicts Cardiovascular Mortality in Patients on Peritoneal Dialysis.

The Association between Baseline Serum Lipids and Mortality in Peritoneal Dialysis Patients

High Alkaline Phosphatase and Low Intact Parathyroid Hormone Associate with Worse Clinical Outcome in Peritoneal Dialysis Patients

Serum Uric Acid and Endothelial Dysfunction in Continuous Ambulatory Peritoneal Dialysis Patients.

A longitudinal analysis of the relationship between serum uric acid and residual renal function loss in peritoneal dialysis patients

Serum Uric Acid and Mortality Risk Among Hemodialysis Patients

The Associations of Blood Pressure Parameters with All-Cause and Cardiovascular Mortality in Peritoneal Dialysis Patients: a Cohort Study in China.

Low Serum Uric Acid Levels Increase the Risk of All-Cause Death and Cardiovascular Death in Hemodialysis Patients.

Association of very Low-density Lipoprotein Cholesterol with All-cause and Cardiovascular Mortality in Peritoneal Dialysis.

High uric acid or low uric acid which is better for hemodialysis patients?

Associations of Mean Arterial Pressure Levels with Mortality in Patients with Peritoneal Dialysis

Relationship between Serum Uric Acid and Mortality Risk in Hemodialysis Patients: A Multicenter Prospective Cohort Study

Low-Density Lipoprotein Cholesterol and Mortality in Peritoneal Dialysis